Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

The treatment was ineffective in humans.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Upadacitinib may cause hair loss.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.